At apoQlar, we are committed to raising awareness and providing insights on critical health issues. Today, we turn our focus to liver cancer, a condition that affects thousands of lives worldwide. Understanding liver cancer can lead to early detection and more effective treatment, ultimately saving lives. Liver cancer, or hepatic cancer, begins in the cells of the liver. The most common type is hepatocellular carcinoma (HCC), which starts in the main type of liver cell (hepatocyte). Several factors can increase the risk of developing liver cancer: • Chronic infection with hepatitis B or C virus • Cirrhosis (scarring of the liver) • Certain inherited liver diseases • Diabetes • Nonalcoholic fatty liver disease • Exposure to aflatoxins (poisons produced by molds that grow on crops) • Excessive alcohol consumption We leverage cutting-edge technology to enhance medical imaging and treatment planning. Our HoloMedicine® Platform uses extended reality to assist surgeons in visualizing liver anatomy and tumors with unparalleled clarity ahead of surgical procedures. This innovation aims to improve patient outcomes. Awareness and early detection are crucial in the fight against liver cancer. Together, we can make strides in combating this challenging disease! #LiverCancer #CancerAwareness #medtech #healthcare #doctors
apoQlar medical’s Post
More Relevant Posts
-
🌐 Today marks #InternationalImmunologyDay, a discipline that plays an essential role in #healthcare and is transforming the landscape of modern #medicine. 🔬 At Bristol Myers Squibb we have been working tirelessly for over two decades to positively impact the lives of #patients facing serious immune pathologies through our innovative #Science. In addition, the past few years have brought major scientific breakthroughs and achievements in the field, such as: 👉 Organ transplantation 👉 Immunotherapy against #cancer. 👉 Primary Immunodeficiencies (There are 500 immunodeficiencies of genetic cause). 👉 Autoimmune Diseases (there are 100 autoimmune diseases) 👉 Development of #vaccines. ❓ Did you know that #psoriasis is an autoimmune disease? Psoriasis is not contagious, can occur at any age and affects both genders equally. Find out here more details about this systemic, chronic, widely prevalent, immune-mediated disease and learn about the factors that can trigger it ➡️ https://lnkd.in/dtYk5yvZ #InternationalDayOfImmunology #DayofImmunology #ThankYouImmunology #Inmunology #BMSIberia #BMSPortugal #BMSCommunity #BMSTransformingLives #WorkingTogetherforPatients #BMSTransformingPatientsLives
To view or add a comment, sign in
-
Why is the Awareness of Transfusion-Transmitted Diseases Crucial for the #BloodScreening Market? The increasing awareness about the transfusion transmitted #diseases has emerged as a major driver propelling the growth of the #bloodscreeningindustry. The escalating awareness surrounding transfusion-transmitted diseases (#TTDs) has emerged as a pivotal driver propelling the growth of the blood screening industry. the surge in demand for donated blood for various medical applications has emerged as a pivotal driver propelling the growth of the blood screening market. The need for safe and compatible blood transfusions has become increasingly crucial with the escalating prevalence of complex #medicalconditions, #surgeries, and #traumaticinjuries. Various medical procedures, such as organ transplants, cancer treatments, and major surgeries, often necessitate substantial quantities of blood to ensure the well-being and recovery of patients. Key Market Players: Diasorin, Bio-Rad Laboratories, Abbott, Siemens, QuidelOrtho., Grifols, F. Hoffmann-La Roche Ltd., AliveDx, Avioq., Danaher Corporation Explore More Insight: https://lnkd.in/dvwHnWiA #BloodScreeningGrowth #TransfusionTransmittedDiseases #SafeBloodTransfusions #MedicalApplications #PatientRecovery #HealthcareSafety #OrganTransplants #CancerTreatments #SurgicalProcedures #BloodDonation
To view or add a comment, sign in
-
-
Thank you Healio for supporting our #OctoberIs4Livers campaign and sharing the latest news and research about hepatocellular carcinoma (#HCC) in honor of #LiverCancerAwarenessMonth Explore the full article below 👇👇and read about topics such as: 1️⃣Robotic liver resection for HCC 2️⃣How #Type2diabetes heightens risk for HCC in patients with #fattyliver 3️⃣How behavioral data can potential predict HCC in patients with #hepatitisB https://lnkd.in/gnjY2rhy #liver #liverhealth #health
To view or add a comment, sign in
-
Have you considered exploring the immune system as a rich source of biomarkers? At Robust, we specialize in multiplexed microarray technology that transforms health research and diagnostics. Our cutting-edge platform enables the simultaneous detection and analysis of thousands of peptide interactions within each sample, ensuring unparalleled quality and precision. Whether you're focused on... -Pre-clinical research (neurodegenerative and autoimmune diseases; cancer immunotherapies) -Diagnostic discovery (early detection; patient stratification; treatment response prediction) -Drug development (target identification; immunogenicity assessment) ...we can design custom arrays to meet your specific needs, measuring hundreds of binding interactions from small volume samples. Our approach is cost-effective, sensitive, and reproducible, making it ideal for accelerating your research and development. #Biomarkers #Diagnostics #Immunology #PeptideMicroarray #PrecisionMedicine
To view or add a comment, sign in
-
Trailblazer in Unveiling the Potential of Structured Reporting, Data-Driven Radiology, and Integrated Diagnostics
A study conducted by researchers at University Hospital Tuebingen, Germany retrospectively compared two liver-targeted therapies for uveal melanoma patients with liver metastases. The results showed that Chemosaturation-Percutaneous Hepatic Perfusion (CS-PHP) had significantly longer overall survival (516 days) compared to Transarterial Radioembolization (SIRT) (300.5 days). #mintLesion was used to assess the treatment efficacy in line with the Response Evaluation Criteria in Solid Tumors (RECIST 1.1). The study observed that the disease control rate, which includes Complete Response (CR), Partial Response (PR), and Stable Disease (SD), was 18% for SIRT and 30% for CS-PHP. These findings highlight the need for further research and prospective randomized trials to optimize liver-targeted treatment strategies and address the challenges faced by patients with this condition. #RECIST #cancerresearch
Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis
To view or add a comment, sign in
-
World Liver Cancer Awareness Month, observed every October, is a crucial global initiative aimed at raising awareness about liver cancer and its significance. This observance serves as a platform to educate people about the risk factors, symptoms, and prevention of this deadly disease. Liver cancer is a growing health concern worldwide, with a high mortality rate, but early detection can significantly improve survival rates. Raising awareness during this month emphasizes the importance of regular screenings, healthy lifestyle choices, and vaccination against hepatitis B, a leading cause of liver cancer. By spreading knowledge about liver cancer, we can empower individuals to take proactive steps to protect their liver health, ultimately reducing the impact of this disease on a global scale. #livercancer #livercancerawareness #cancer #wembrace . . DISCLAIMER: THIS POST DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, images, and other material contained in this post is for informational purposes only. No material on this post is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider. . . To learn more - www.wembrace.in . . #wembracebiopharma #liver #cancerawarness #raiseawareness #medical #embracegoodhealth #healthcare #oncology #october #pharmaceutical #liverchat #livercancer #pancreaticcancer #liverdisease #cancersucks #liverdisease #hepatitisb #cancerpatient #liverhealth #leukemia #health #nash #medicine #healthylifestyle #deadlydisease #disease
To view or add a comment, sign in
-
⏰ Last day to register for our live webinar! Tomorrow at 4 PM CET, Lenie van den Broek will share insights on phenotypic disease modeling for inflammation and how 3D disease models advance the discovery of immune-targeting therapies! 💡 What you'll learn: - Case study on mechanism of action and antibody ranking in vascular inflammation assays - Using complement activated serum in immune-competent renal models - Capturing key IBD mechanisms with adult stem cell-derived gut organoid models - Benefits of partnering with MIMETAS to accelerate your research and improve the selection of your immunomodulatory compounds 🔗 Register now: https://lnkd.in/gxbx_yaH #Webinar #DrugDiscovery #Inflammation #ImmuneTherapies #IBD
To view or add a comment, sign in
-
There’s no one quite like you, so why receive the same health care as everyone else? GeneType Multi-Risk Test takes personalised risk assessment to new levels with a risk assessment that allows you to choose what to test for*. Learn more today: https://lnkd.in/gjjUuydV While many risk assessments focus on family history and inherited genetic markers, the geneType Multi-Risk Test goes beyond this by incorporating clinical, familial and genetic risk factors that affect disease risk. Know your risk, reduce your risk and take control of your health with #geneType *Tests for breast cancer, colorectal cancer, prostate cancer, ovarian cancer, coronary artery disease and type 2 diabetes are currently available in Australia. #KnowYourRisk #healthcare #preventativemedicine #prevention #womenshealth #menshealth #precisionmedicine #breastcancer #prostatecancer #heartdisease #earlydetectionsaveslives
To view or add a comment, sign in
-